Australia's largest stock trading and investment forum Australia's #1 stock forum

ATH

Click for more information

25.0%

0.5¢ alterity therapeutics limited

Yeh, being invited too and speaking in front of an elite class,...

First 5 Last

Share
Profile

Follow
Scottsmyname

388 Posts.

22

30/03/24

22:12

Post #: 73126893
Share

Originally posted by pivalde: ↑

Yes, it is also a good possibility and maybe Stamler wants to inform the main news even if he does not know the result of the randomized study. His talk is about alpha-synuclein. The effect of it has been told in several ATH434 studies both in MSA and PD animal models and now they also have info on it in the open study. So it is perhaps easy to make some comments about the hypothesis of this randomized study (A Phase 2 Study of ATH434, a Novel Inhibitor of α-synuclein Aggregation, for the Treatment of Multiple System Atrophy (MSA)).

Expand

Yeh, being invited too and speaking in front of an elite class, you would want to impress and show most of your cards, and having a one hour presentation, it should be enough to cover alot of ground.

I feel he would have to leak some noted changes of the study group.

ATH Price at posting: 0.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 15 more messages in this thread...

First 5 Last

Add ATH (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.001(25.0%)		Mkt cap ! $26.22M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$10.54K	2.185M

Buyers (Bids)

No.	Vol.	Price($)
59	83226460	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	20397608	18

View Market Depth

No.	Vol.	Price($)
59	83226460	0.004
50	53735564	0.003
16	38993014	0.002
12	93270101	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	20397608	18
0.006	16372811	23
0.007	17174670	18
0.008	14585875	16
0.009	6171000	7

Last trade - 10.13am 07/06/2024 (20 minute delay)

ATH (ASX) Chart